Jendo Innovations Featured Among 20 Deep-Science Patent Holders in WIPO Global Innovation Index 2026
Jendo is one of only 20 companies in WIPO's table of top deep-science patent holders in middle-income economies, representing Sri Lanka in Medical Devices and Digital Health.
Jendo Innovations Inc. has been featured in the World Intellectual Property Organization (WIPO) Global Innovation Index 2026, marking an important milestone for the company and for Sri Lanka's growing deep-science and MedTech ecosystem.
In the 2026 report, WIPO lists Jendo in its table "The top deep science patent holders in middle-income economies, by economy, 2010–2025." Jendo is one of only 20 companies in this global table and represents Sri Lanka in the Medical Devices and Digital Health sector.
The list brings together deep-science innovators from economies including China, Malaysia, India, Brazil, South Africa, Türkiye, Egypt, Indonesia, Thailand and Mexico, showing how science-based companies from emerging economies are building protected intellectual property and turning research into commercially relevant technologies.
What is the Global Innovation Index?
Published annually by WIPO, the Global Innovation Index is one of the world's leading references for understanding innovation performance and ecosystems. The 2026 edition focuses on deep-science entrepreneurship under the theme "Powering entrepreneurs at the frontier of science: Turning pilots into pipelines."
WIPO reports that more than 30,000 deep-science startups have been created globally since 2000, and that they are now collectively valued at approximately USD 7.6 trillion.
Why Jendo's inclusion matters
Patents play a central role in deep-science commercialization. According to WIPO, around 50% of deep-science startups hold patents, compared with only 15.4% of other startups, and Medical Devices and Digital Health is the most patent-intensive deep-science sector. Because these companies often need years of R&D before reaching the market, patents become key assets for investment, partnerships, licensing and international expansion. For Jendo, intellectual property protection has been part of the strategy from the earliest stages of development.
From Sri Lankan research to global recognition
Jendo's journey began with a fundamental healthcare question: can vascular dysfunction be identified early enough to support preventive cardiovascular care? The company went on to develop a non-invasive vascular health screening technology that combines biomedical sensing, signal processing, artificial intelligence and data analytics. It assesses vascular endothelial function from physiological signals collected at a patient's fingertip, helping identify abnormalities associated with cardiovascular risk.
WIPO has previously highlighted Jendo's journey and its patented cardiovascular screening technology on its Global Health and IP Advantage platforms.
One of 20 companies highlighted by WIPO
The GII 2026 table includes 20 companies from 20 middle-income economies, among them Changxin Memory Technologies (China), Lemonex (Malaysia), Qure.AI (India), HiLab (Brazil), LIQID Medical (South Africa), Mogassam (Egypt), Octavia Carbon (Kenya) and Jendo Innovations (Sri Lanka). Being listed alongside them shows what is possible when research, engineering, clinical science and intellectual property are developed with a long-term vision.
More than a recognition
This milestone reflects more than a decade of research, biomedical engineering, clinical validation, intellectual property development and regulatory work, and the collective contribution of researchers, engineers, doctors, universities, team members, investors, mentors, institutions, partners and families.
Sri Lanka has the scientific and engineering talent to build more globally relevant deep-science companies. The challenge now is to create the research infrastructure, investment pathways, IP strategies, regulatory frameworks and entrepreneurial ecosystem to build many more.
For Jendo, this recognition is another milestone, not the destination. We will continue building the next chapter of Sri Lankan deep-science innovation and taking locally developed healthcare technology to the world.
